The "Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2025" has been added to ResearchAndMarkets.com's offering.

This report contains a comprehensive listing of co-promotion and co-marketing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals. Fully revised and updated, the report provides details of co-promotion and co-marketing deals from 2016 to 2025.

The report provides access to co-promotion and co-marketing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

The initial chapters of the report serve as a foundation to understanding co-promotion and co-marketing deals. Chapter 1 introduces the report, while Chapter 2 delves into trend analysis and the advantages of such deals. Chapter 3 outlines deal structures, and Chapter 4 reviews notable deals since 2016, providing links to SEC-published agreements. Chapter 5 lists the top 25 active dealmaking companies with links to detailed records. Chapter 6 organizes deals by company, therapy, technology, and industry, offering in-depth insights into agreed terms. Overall, the chapters collectively offer a thorough orientation on the business activities and intricacies involved in co-promotion and co-marketing dealmaking.

Understand Deal Trends Since 2016

• Browse co-promotion and co-marketing deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in co-promotion and co-marketing dealmaking

2.1. Introduction

2.2. Definition of co-promotion and co-marketing deals

2.3. Trends in co-promotion and co-marketing deals since 2016

2.3.1. Co-promotion and co-marketing dealmaking by year, 2016-2025

2.3.2. Co-promotion and co-marketing dealmaking by phase of development, 2016-2025

2.3.3. Co-promotion and co-marketing dealmaking by industry sector, 2016-2025

2.3.4. Co-promotion and co-marketing dealmaking by therapy area, 2016-2025

2.3.5. Co-promotion and co-marketing dealmaking by technology type, 2016-2025

2.3.6. Co-promotion and co-marketing dealmaking by most active company, 2016-2025

2.4. Reasons for entering into co-promotion and co-marketing partnering deals

2.5. The future of co-promotion and co-marketing deals

Chapter 3 - Overview of co-promotion and co-marketing deal structure

3.1. Introduction

3.2. Co-promotion and co-marketing agreement structure

Chapter 4 - Leading co-promotion and co-marketing deals

4.1. Introduction

4.2. Top co-promotion and co-marketing deals by value

Chapter 5 - Top 25 most active co-promotion and co-marketing dealmakers

5.1. Introduction

5.2. Top 25 most active co-promotion and co-marketing dealmakers

Chapter 6 - Co-promotion and co-marketing deals including contracts directory

6.1. Introduction

6.2. Co-promotion and co-marketing deals with contracts 2016-2025

Deal directory

• Deal directory - Co-promotion and co-marketing dealmaking by companies A-Z
• Deal directory - Co-promotion and co-marketing dealmaking by therapy area
• Deal directory - Co-promotion and co-marketing dealmaking by technology type

Companies Featured (Partial)

• 3D Medicines
• Abbvie
• Acellan Pharmaceuticals
• Adaptimmune
• Advanced Biological Laboratories
• AEterna Zentaris
• Agilent Technologies
• Ajinomoto
• Allegis Pharmaceuticals
• Alnylam Pharmaceuticals
• Amneal Pharmaceuticals
• Apellis Pharmaceuticals
• Arcus Biosciences
• Arrowhead Pharmaceuticals
• Assembly Biosciences
• AstraZeneca
• BeiGene
• Biogen
• BioNTech
• Bristol-Myers Squibb
• BridgeBio Pharma
• Celgene
• CytomX Therapeutics
• DexCom
• Eisai
• Eton Pharmaceuticals
• Ferring Pharmaceuticals
• Genentech
• GSK
• Halyard Health
• Illumina
• Incyte
• Intellia Therapeutics
• Janssen Biotech
• Lundbeck
• Merck and Co
• Mitsubishi Tanabe Pharma
• Moderna
• Novartis
• Pfizer
• Precision BioSciences
• Regeneron Pharmaceuticals
• Sanofi
• Sarepta Therapeutics
• Seagen
• Sutro Biopharma
• Takeda Pharmaceutical
• Thermo Fisher Scientific
• UCB
• Vertex Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/3kao2v

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250702117459/en/